1051. Misbranding: of sterile solution of sodium citrate. U. S. v. The National
Drug Co. Plea of nolo contendere. Fine, $4,000. (F. D. C. No. 9670.
Sample Nos. 3633-F, 5762-F, 11611-F, 29380-F, 29472-F, 34613-F, 37501-F,
41782-F.) 
On July 15,1943, the United States attorney for the Eastern District of Pennsyl-
vania filed an information against the National Drug Co., a corporation, Philadel-
phia, Pa., alleging shipment from on or about November 11 to December 31,1942,
from the State of Pennsylvania into the States of Kansas, Missouri, Colorado,
Georgia, Virginia, and Ohio of quantities of the above-named product, which was
misbranded.
Examination of samples disclosed that the article contained pyrogens.
The article was alleged to be misbranded in that, by reason of the presence of
pyrogens, it was dangerous to health when used in the dosage prescribed, recom-
mended, and suggested in the labeling, "The contents of a 50 cc. ampul containing
the 2?? solution, mixed with 450 cc. of blood produces a transfusion mixture."
It was alleged to be misbranded further in that the statement in its labeling, "For
use in transfusions to prevent the clotting of blood," was misleading, since the
*For omission of, or unsatisfactory, ingredients statements, see Nos. 1053, 1075,1087,1088,1093,1097,1100;
failure to bear adequate statements of quantity of contents, Nos. 1055, 1062,1075,1099; cosmetic, subject to
the drug provisions of the Act, Nos. 1073,1090.
631214?45 1 
235
article would not be safe or appropriate for use in transfusions to prevent the
clotting of blood.
On September 22, 1943. the defendant having, entered a plea of nolo contendere,
the court imposed a fine of $500 on each of 8 counts, a total of $4,000.